Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

GRANT Life Sciences, Inc. Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   31
ISBN Number   not applicable
Product Code   GMD640
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a GRANT Life Sciences, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Industry Outlook - In Vitro Diagnostics
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Company Statement
  • 9 Locations And Subsidiaries
    • 9.1 Head Office
    • 9.2 Other Locations & Subsidiaries
  • 10 Recent Developments
    • 10.1 Strategy And Business Planning
      • 10.1.1 Oct 27, 2006: Grant To Explore Expanded Partnership With DTL
    • 10.2 Corporate Communications
      • 10.2.1 Mar 26, 2007: Grant Life CFO Retires, Appoints New CFO
    • 10.3 Legal and Regulatory
      • 10.3.1 Jan 16, 2007: Grant Signs MOU With UCl
      • 10.3.2 Apr 12, 2006: Grant Enters MoU With DTL
    • 10.4 Product News
      • 10.4.1 Jan 22, 2008: Chinese And U.S. patents Issue To Grant Life Sciences For Its Blood Test That Detects Cervical Cancer
      • 10.4.2 Nov 13, 2007: Grant Life Sciences In-licenses HPV DNA-based Test From Alphagenics
      • 10.4.3 Nov 13, 2007: Grant Life Sciences In-Licenses HPV DNA-based Test From Alphagenics
      • 10.4.4 Apr 12, 2006: Grant Life Sciences (Grant'') Enters Into a Memorandum of Understanding with Diagnostic Technologies Ltd. (DTL'') to Develop and Commercialize Grant''s Cervical Cancer-Diagnostic Technology
  • 11 GRANT Life Sciences, Inc. Pipeline Products
    • 11.1 GRANT Life Sciences, Inc. Product Pipeline Analysis
      • 11.1.1 GRANT Life Sciences, Inc. Pipeline Products By Equipment Type
      • 11.1.2 GRANT Life Sciences, Inc. Pipeline Products By Development Stage
      • 11.1.3 GRANT Life Sciences, Inc. Pipeline Products By Therapy Area
      • 11.1.4 GRANT Life Sciences, Inc. Pipeline Products By News Summary
    • 11.2 Cervical Diagnostic
      • 11.2.1 Product Description
      • 11.2.2 Product Status
      • 11.2.3 Product Milestone
    • 11.3 HPV DNA-based Test
      • 11.3.1 Product Description
      • 11.3.2 Product Status
      • 11.3.3 Product Milestone
    • 11.4 Serum-based test for detecting Cervical Cancer
      • 11.4.1 Product Description
      • 11.4.2 Product Status
      • 11.4.3 Product Milestone
      • 11.4.4 Product Patent Details
  • 12 Appendix
    • 12.1 Methodology
      • 12.1.1 Coverage
      • 12.1.2 Secondary Research
      • 12.1.3 Primary Research
      • 12.1.4 Expert Panel Validation
    • 12.2 Contact Us
    • 12.3 About Global Markets Direct
    • 12.4 Disclaimer
  • 1 List of Tables
    • Table 1: GRANT Life Sciences, Inc.,Key Facts
    • Table 2: GRANT Life Sciences, Inc., Key Employees,
    • Table 3: GRANT Life Sciences, Inc., Other Locations
    • Table 4: GRANT Life Sciences, Inc. Pipeline Products by Equipment Type
    • Table 5: GRANT Life Sciences, Inc. Pipeline Products By Development Stage
    • Table 6: GRANT Life Sciences, Inc. Pipeline Products By Therapy Area
    • Table 7: GRANT Life Sciences, Inc. Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: GRANT Life Sciences, Inc. Pipeline Products By Equipment Type
    • Figure 2: GRANT Life Sciences, Inc. Pipeline Products By Equipment Type
    • Figure 3: GRANT Life Sciences, Inc. Pipeline Products By Development Stage
    • Figure 4: GRANT Life Sciences, Inc. Pipeline Products By News Summary
    • Figure 5: Global Markets Direct Methodology